Mairene Coto-Llerena

Visceral Surgery and Precision Medicine Research Laboratory, University of Basel

Research Area

Biography

Mairene Coto-Llerena has not added Biography.
If you are Mairene Coto-Llerena and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2024

Other Publications

Article	Year
SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression . The Journal of biological chemistry\| PubMed ID: 28900038	2017
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors. Hepatology communications\| PubMed ID: 31334445	2019
Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation. Nature communications\| PubMed ID: 32286285	2020
A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer. Cancer research\| PubMed ID: 32586983	2020
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes. Frontiers in oncology\| PubMed ID: 32733792	2020
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer. Cancer immunology research\| PubMed ID: 32839156	2020
Interferon lambda 4 can directly activate human CD19 B cells and CD8 T cells. Life science alliance\| PubMed ID: 33158978	2021
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis. Theranostics\| PubMed ID: 33754045	2021
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members. Hepatology communications\| PubMed ID: 33860124	2021
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis. Oncogenesis\| PubMed ID: 34272356	2021
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens. Nucleic acids research\| PubMed ID: 34313788	2021
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses. Nature communications\| PubMed ID: 34385466	2021
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO molecular medicine\| PubMed ID: 34664408	2021
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization. Cell reports. Medicine\| PubMed ID: 34841291	2021
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma. Molecular oncology\| PubMed ID: 34863035	2022
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues. Frontiers in oncology\| PubMed ID: 35083141	2021
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma. JCO precision oncology\| PubMed ID: 35263170	2022
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Communications biology\| PubMed ID: 35440675	2022
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages. Nature communications\| PubMed ID: 35508466	2022
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report. Communications medicine\| PubMed ID: 35603298	2022
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Communications biology\| PubMed ID: 35787660	2022
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report. Communications medicine\| PubMed ID: 35789568	2022
The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective. Frontiers in medicine\| PubMed ID: 35814741	2022
Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis. Nature communications\| PubMed ID: 35987910	2022
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens. Nature communications\| PubMed ID: 36517508	2022
Arginine reprograms metabolism in liver cancer via RBM39. Cell\| PubMed ID: 37804830	2023
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. NPJ precision oncology\| PubMed ID: 37919480	2023